DIN 02248762 — PMS-MIRTAZAPINE 30 MG
PMS-MIRTAZAPINE is a tablet of Mirtazapine marketed by PHARMASCIENCE INC. The full Mirtazapine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02248762
- Brand name
- PMS-MIRTAZAPINE
- Active ingredient
- Mirtazapine
- Strength
- 30 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PHARMASCIENCE INC
- Health Canada status
- DORMANT
- Drug class
- Atypical antidepressant (noradrenergic and specific serotonergic antidepressant, NaSSA)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mirtazapine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02286610 | APO-MIRTAZAPINE | 15 MG | TABLET | APOTEX INC | MARKETED |
| 02286629 | APO-MIRTAZAPINE | 30 MG | TABLET | APOTEX INC | MARKETED |
| 02286637 | APO-MIRTAZAPINE | 45 MG | TABLET | APOTEX INC | MARKETED |
| 02411695 | AURO-MIRTAZAPINE | 15 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02411709 | AURO-MIRTAZAPINE | 30 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02411717 | AURO-MIRTAZAPINE | 45 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02299801 | AURO-MIRTAZAPINE OD | 15 MG | TABLET (ORALLY-DISINTEGRATING) | AURO PHARMA INC | MARKETED |
| 02299828 | AURO-MIRTAZAPINE OD | 30 MG | TABLET (ORALLY-DISINTEGRATING) | AURO PHARMA INC | MARKETED |
| 02299836 | AURO-MIRTAZAPINE OD | 45 MG | TABLET (ORALLY-DISINTEGRATING) | AURO PHARMA INC | MARKETED |
| 02368560 | JAMP-MIRTAZAPINE | 15 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT |
| 02368579 | JAMP-MIRTAZAPINE | 30 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT |
| 02496666 | MIRTAZAPINE | 15 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02532689 | MIRTAZAPINE | 15 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02370689 | MIRTAZAPINE | 30 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02496674 | MIRTAZAPINE | 30 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02496682 | MIRTAZAPINE | 45 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02256096 | MYLAN-MIRTAZAPINE | 15 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02256118 | MYLAN-MIRTAZAPINE | 30 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02256126 | MYLAN-MIRTAZAPINE | 45 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02534924 | NRA-MIRTAZAPINE | 15 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02534932 | NRA-MIRTAZAPINE | 30 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02534940 | NRA-MIRTAZAPINE | 45 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02273942 | PMS-MIRTAZAPINE | 15 MG | TABLET | PHARMASCIENCE INC | DORMANT |
| 02312778 | PRO-MIRTAZAPINE | 15 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02312786 | PRO-MIRTAZAPINE | 30 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02243910 | REMERON | 30 MG | TABLET | ORGANON CANADA INC. | MARKETED |
| 02248542 | REMERON RD | 15 MG | TABLET (ORALLY-DISINTEGRATING) | ORGANON CANADA INC. | MARKETED |
| 02248543 | REMERON RD | 30 MG | TABLET (ORALLY-DISINTEGRATING) | ORGANON CANADA INC. | MARKETED |
| 02248544 | REMERON RD | 45 MG | TABLET (ORALLY-DISINTEGRATING) | ORGANON CANADA INC. | MARKETED |
| 02250594 | SANDOZ MIRTAZAPINE | 15 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02250608 | SANDOZ MIRTAZAPINE | 30 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02541572 | TEVA-MIRTAZAPINE | 15 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02259354 | TEVA-MIRTAZAPINE | 30 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02541580 | TEVA-MIRTAZAPINE | 45 MG | TABLET | TEVA CANADA LIMITED | MARKETED |